Zacks Investment Research upgraded shares of CYBIN INC. (CYBN.NE) (OTCMKTS:CYBN) from a hold rating to a buy rating in a report issued on Tuesday morning, Zacks.com reports. Zacks Investment Research currently has $2.25 target price on the stock.
Betting on bargain stocks that have a low price-to-earnings (P/E) ratio is a convenient and common investment approach. The perception is that the lower the P/E, the higher is the value of the stock. This inference is drawn on the simple logic that a stock’s current market price does not justify (is not equivalent to) its higher earnings and therefore has room to run.
Naturally, there are very few investors who pay attention to stocks with an increasing P/E. But this often-overlooked trend can prove useful in finding great stocks. Let’s dig a little deeper.
News headlines about Aratana Therapeutics (NASDAQ:PETX) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Aratana Therapeutics earned a media sentiment score of 0.14 on Accern’s scale. Accern also gave news headlines about the biopharmaceutical company an impact score of 46.3639333227151 out of....More>>>
Wheaton Precious Metals Corp. (NYSE:WPM) is one of the largest silver and gold streaming companies in the world. However, over the last five years, Wheaton’s stock is down nearly 10% while peers Royal Gold, Inc. (NASDAQ:RGLD) and Franco-Nevada Corporation (NYSE:FNV) are up over 60% each. What’s going on at Wheaton, and is it worth buying what clearly looks like the industry laggard?
An advantaged model
The first thing to understand about Wheaton and its peers is the streaming business model. Essentially, these companies provide cash up front to miners for the right....More>>>
Brasada Capital Management LP grew its stake in shares of Columbia Sportswear (NASDAQ:COLM) by 25.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,669 shares of the textile maker’s stock after purchasing an additional 1,148 shares during the quarter. Brasada Capital Management LP’s holdings in Columbia Sportswear were worth $433,000 as of its most recent SEC filing.
Several other large investors also recently bought and sold shares of COLM. Teacher Retirement System of Texas bought a new position....More>>>
Over the last 25-plus years, Amazon (NASDAQ:AMZN) has transformed from merely a retail company to a collection of services for merchants, enterprises, and consumers. That's a playbook its competitors are eager to follow, and Walmart (NYSE:WMT), largely following in Amazon's footsteps, has drama
As nations push for sustainable automotive technologies, electric vehicle (EV) start-up Fisker (NYSE:FSR) seems like a sure bet for powerful profits. Yet, FSR stock has fallen sharply from its peak price.
WESPAC Advisors LLC boosted its holdings in AbbVie Inc. (NYSE:ABBV – Get Rating) by 82.0% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 17,063 shares of the company's stock after acquiring an addition
Shares of The Buckle, Inc. (BKE Quick QuoteBKE ) have surged 36.6% year to date, thanks to the company’s impressive sales numbers for quite some time now. Strength in its online business amid the pandemic has been impressive so far. Solid gains from the company’s women&rsqu